Related Experiment Video
Updated: Feb 1, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient
Esther J Kim1,2, Alexander B Aria2,3, Kelly Wilmas2,3
1School of Medicine, Baylor College of Medicine, Houston, Texas.
Abstract:
Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder (PCSM-LPD) is a rare and low-grade form of cutaneous T-cell proliferation with the average age of diagnosis of 54 years. Because of its rarity, the etiology or exact clinicopathology of PCSM-LPD remains unclear, with < 10 pediatric cases reported. A 13-year-old boy presented to our clinic with a raised tumor with PCSM-LPD histology and was successfully treated with ultra-low-dose radiation therapy. While no standard of care has been established for pediatric PCSM-LPD, this report represents an example of achieving remission in a pediatric tumor with minimal potential for therapy-related long-term toxicity.
Related Concept Videos
Dose Size and Dosing Frequency: Determination Methods
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Geriatric Patients
Biological Effects of Radiation
Drug Dosing: Obese Patients
Pharmacokinetics in Pediatric Patients: Drug Distribution

